Venlafaxine: Discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites

Synapse

Volumn 32, Issue 3, 1999, Pages 198-211

  Béïque, Jean Claude ^a   De Montigny, Claude ^a   Blier, Pierre ^a   Debonnel, Guy ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Antidepressant; Desipramine; Dorsal raphe; Fenfluramine; Locus coeruleus; Paroxetine; Releaser; Tyramine

Indexed keywords

DESIPRAMINE; FENFLURAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PIPEROXAN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TYRAMINE; VENLAFAXINE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; INTRAVENOUS DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; MONOAMINE RELEASE; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC NERVE; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL;

ACTION POTENTIALS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BINDING SITES; CYCLOHEXANOLS; DESIPRAMINE; FENFLURAMINE; HIPPOCAMPUS; LOCUS COERULEUS; MALE; NEURONS; NOREPINEPHRINE; PAROXETINE; PIPERAZINES; PIPEROXAN; PYRIDINES; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TYRAMINE;

EID: 0344867884     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(19990601)32:3<198::AID-SYN6>3.0.CO;2-2     Document Type: Article

References (69)

1. Adell A, Artigas F. 1991. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn Schmiedebergs Arch Pharmacol 343:237-244.
2. Aghajanian GK. 1978. Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies. In: Youdim MBH, Lovenberg W, Sharman DF, Lagnado JR, editors. Essays in neurochemistry and neuropharmacology 3rd ed. New York: John Wiley & Sons. p 1-32.
3. Anderson C, Pasquier W, Forbes W, Morgane P. 1977. Locus coeruleus-to-dorsal raphe input examined by electrophysiological and morphological methods. Brain Res Bull 2:209-221.
4. Aston-Jones G, Akaoka H, Charléty PJ, Chouvet G. 1991a. Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J Neurosci 11:760-769.
5. Aston-Jones G, Shipley MT, Chouvet G, Ennis M, Van Bockstaele EJ, Pieribone VA, Shiekhattar R, Akaoka H, Drolet G, Astier B, Charléty PJ, Valentino RJ, Williams JT. 1991b. Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog Brain Res 88:47-75.
6. Baraban JM, Aghajanian GK. 1980a. Suppression of serotonergic neuronal firing by alpha-adrenoceptor antagonists: evidence against GABA mediation. Eur J Pharmacol 66:287-294.
7. Baraban JM, Aghajanian GK. 1980b. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19:355-363.
8. Béïque JC, de Montigny C, Blier P, Debonnel G. 1998a. Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine. Br J Pharmacol 125:526-532.
9. Béïque JC, Lavoie N, de Montigny C, Debonnel G. 1998b. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. Eur J Pharmacol 349:129-132.
10. Benkert O, Grunder G, Wetzel H, et al. 1996. A randomized double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia. J Psychiatr Res 30:441-451.
11. Blier P, Bouchard C. 1993. Functional characterization of a 5-HT3 receptor which modulates the release of 5-HT in the guinea-pig brain. Br J Pharmacol 108:13-22.
12. Blier P, de Montigny C, Tardif D. 1984. Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single cell studies in the rat. Psychopharmacology 84:242-249.
13. Blier P, Galzin AM, Langer SZ. 1990. Interaction between serotonin uptake inhibitors and alpha-2 adrenergic heteroreceptors in the rat hypothalamus. J Pharmacol Exp Ther 254:236-244.
14. Bolden-Watson C, Richelson E. 1993. Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 52:1023-1029.
15. Carruba MO, Picotti GB, Zambotti F, Mantegazza P. 1977. Effects of mazindol, fenfluramine and chloroimipramine on the 5-hydroxytryptamine uptake and storage mechanisms in rat brain: similarities and differences. Naunyn Schmiedebergs Arch Pharmacol 300:227-232.
16. Ceci A, Borsini F. 1996. Effects of desipramine and maprotiline on the coeruleus-cortical noradrenergic system in anaesthetized rats. Eur J Pharmacol 312:189-193.
17. Cedarbaum JM, Aghajanian GK. 1978. Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J Comp Neurol 178:1-16.
18. Chaput Y, de Montigny C, Blier P. 1986. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat. Naunyn Schmiedebergs Arch Pharmacol 33:342-349.
19. Cheetham SC, Viggers JA, Slater NA, Heal DJ, Buckett WR. 1993. [3H]Paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology 32:737-743.
20. Cheetham SC, Viggers JA, Butler SA, Prow MR, Heal DJ. 1996. [3H]Nisoxetine - a radioligand for noradrenaline reuptake sites: correlation with inhibition of [3H] noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments. Neuropharmacology 35:63-70.
21. Clerc GE, Ruimy P, Verdeau-Pailles J. 1994. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalised for major depression and melancholia. Int Clin Psychopharmacol 9:139-143.
22. Cusack B, Nelson A, Richelson E. 1994. Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology 114:559-565.
23. de Montigny C, Blier P, Caille G, Kouassi E. 1981. Pre- and postsynaptic effect of zimelidine and norzimelidine on the serotonergic system: single cell studies in the rat. Acta Psychiatr Scand 63:S79-S80.
24. de Montigny C, Chaput Y, Blier P. 1990. Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. J Clin Psychiatry 51:4-8.
25. de Montigny C, Silverstone H, Bakish D, Blier P, Debonnel G. 1999. Venlafaxine in treatment-resistant major depression: a Canadian multicentre open-label trial. J Clin Psychopharmacol (in press).
26. Dierick M, Ravizza L, Realini R, et al. 1996. A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients. Prog Neuropsychopharmacol Biol Psychiatry 20:51-57.
27. 1A autoreceptors and noradrenergic mechanisms. Psychopharmacology 130:261-268.
28. Guelfi JD, White C, Magni G. 1992. A randomized, double blind comparison of venlafaxine and placebo in inpatients with major depression and melancholia. Clin Neuropharmacol 15:19-168.
29. Haddjeri N, de Montigny C, Blier P. 1997. Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxytryptamine system. Br J Pharmacol 120:865-875.
30. Haigler HJ, Aghajanian, GK. 1974. Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurons receiving a serotonergic input. J Pharmacol Exp Ther 168:688-699.
31. Hajós M, Gartside SE, Sharp T. 1995. Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn Schmiedebergs Arch Pharmacol 624-629.
32. Haskins JT, Moyer JA, Muth EA, Sigg EB. 1985. DMI, Wy-45,030, Wy-45,881 and ciramadol inhibit locus coeruleus neuronal activity. Eur J Pharmacol 115:139-146.
33. Howell SR, Husbands GE, Scatina JA, Sisenwine SF. 1993. Metabolic disposition of 14C-venlafaxine in mouse, rat, dog, rhesus monkey and man. Xenobiotica 23:349-359.
34. Hyttel J. 1982. Citalopram. Basic studies. Pharmacological profile of a specific uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 6:277-295.
35. Invernizzi R, Bramante M, Samanin R. 1995. Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Brain Res 696:62-66.
36. Kannengiesser MH, Hunt PF, Raynaud JP. 1976. Comparative action of fenfluramine on the uptake and release of serotonin and dopamine. Eur J Pharmacol 35:35-43.
37. Kasamo K, Blier P, de Montigny C. 1996. Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain. J Pharmacol Exp Ther 277:278-286.
38. Kelsey JE. 1996. Dose-response relationship with venlafaxine. J Clin Psychopharmacol 16:21S-28S.
39. Kovachich GB, Aronson CE, Brunswick DJ, Frazer A. 1988. Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine. Brain Res 454:78-88.
40. Kreiss DS, Lucki I. 1995. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther 274:866-876.
41. Lecrubier Y, Moon CAL, Schifano F, et al. 1997. Efficacy of venlafaxine in depressive illness in general practice. Acta Psychiatr Scand 95:485-493.
42. Marcusson JO, Norinder U, Hogberg T, Ross SB. 1992. Inhibition of [3H] paroxetine binding by various serotonin uptake inhibitors: structure-activity relationships. Eur J Pharmacol 215:191-198.
43. Mongeau R, Weiss M, de Montigny C, Blier P. 1998. Milnacipran-1. Effect of acute, short- and long-term administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons. Neuropharmacology 37:905-918.
44. Muth EA, Haskins JT, Moyer JA, Husbands GE, Nielsen ST, Sigg EB. 1986a. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 35:4493-4497.
45. Muth EA, Moyer JA, Andree TH. 1986b. A pharmacological profile of WY-45,233, the major metabolite in humans of the novel bicyclic antidepressant candidate WY-45,030. Soc Neurosci Abstr 12:473.
46. Nierenberg AA, Feighner JP, Rudolph R, Cole JO, Sullivan J. 1994. Venlafaxine for treatment-resistant unipolar depression. J Clin Psychopharmacol 14:419-423.
47. Nyback HV, Walters JR, Aghajanian GK, Roth RH. 1975. Tricyclic antidepressants: effects on the firing rate of brain noradrenergic neurons. Eur J Pharmacol 32:302-312.
48. Pickel VM, Joh TH, Reis DJ. 1977. A serotonergic innervation of noradrenergic neurons in nucleus locus coeruleus: demonstration by immunocytochemical localization of the transmitter specific enzymes tyrosine and tryptophan hydroxylase. Brain Res 131:197-214.
49. Pieribone VA, Van Bockstaele EJ, Shipley MT, Aston-Jones G. 1989. Serotonergic innervation of rat locus coeruleus derives from nonraphe brain areas. Soc Neurosci Abstr 15:420.
50. Piñeyro G, Blier P, Dennis T, de Montigny C. 1994. Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci 14:3036-3047.
51. Pylatuk KL, McNeil, JH. 1976. The effects of certain drugs on the uptake and release of [3H]noradrenaline in rat whole brain homogenates. Can J Physiol Pharmacol 54:457-468.
52. Quinaux N, Scuvée-Moreau J, Dresse A. 1982. Inhibition of in vitro and ex vivo uptake of noradrenaline and 5-hydroxytryptamine by five antidepressants; correlation with reduction of spontaneous firing rate of central monoaminergic neurones. Naunyn Schmiedebergs Arch Pharmacol 319:66-70.
53. 2-adrenoceptor-mediated inhibition of noradrenaline and 5-hydroxytryptamine release in rat hypothalamic slices. Naunyn Schmiedebergs Arch Pharmacol 340: 386-395.
54. 2 antagonists. Brain Res 385:395-400.
55. 1A receptor antagonist in the dorsal raphe pathway: role of somatodendritic autoreceptors. J Neurochem 68:2593-2603.
56. 1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology 15:349-360.
57. 1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neurosci Lett 219:123-126.
58. Rudolph R, Aguiar L, Entsuah R, Derivan A. 1997. Double-blind, placebo-controlled study of once-daily venlafaxine (XR) and fluoxetine in depressed outpatients. NCDEU, 37th Annual Meeting, p 24.
59. Rutter JJ, Gundlah C, Auerbach SB. 1995. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation. Synapse 20:225-233.
60. Sakai K, Salvert D, Touret M, Jouvet M. 1977. Afferent connections of the raphe dorsalis in the cat as visualized by the horseradish peroxidase technique. Brain Res 137:11-35.
61. Schweizer E, Weise C, Clary C, Fox I, Rickels K. 1991. Placebo-controlled trial of venlafaxine for the treatment of major depression. J Clin Psychopharmacol 11:233-236.
62. Schweizer E, Feighner J, Mandos LA, Rickels K. 1994. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. J Clin Psychiatry 55:104-108.
63. Scuvée-Moreau J, Dresse, AE. 1979. Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat. Eur J Pharmacol 57:219-255.
64. Scuvée-Moreau J, Dresse A. 1990. Influence of fenfluramine and norfenfluramine stereoisomers on the firing rate of central monoaminergic neurons in the rat. Eur J Pharmacol 179:211-215.
65. Segal M. 1979. Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on response to noxious stimuli. J Physiol (Lond) 286:401-415.
66. Sheard MH, Zolovick A, Aghajanian GK. 1972. Raphe neurons: effect of tricyclic antidepressant drugs. Brain Res 43:690-694.
67. Sprouse JS, Bradberry CW, Roth RH, Aghajanian GK. 1989. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin. Eur J Pharmacol 167:375-383.
68. Thomas DR, Nelson DR, Johnson AM. 1987. Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology 93:193-200.
69. Wang RY, de Montigny C, Gold BI, Roth RH, Aghajanian GK. 1979. Denervation supersensitivity to serotonin in rat forebrain: single cell studies. Brain Res 178:479-497.